CW October 2003

category image Volume 12
Issue Number 10
October 2003
ISSN 10593802

Anti-tumor Vaccine for Melanoma Patients using Adenovirus Vector

Using an adenovirus vector to generate engineered tumor cells for vaccination in advanced melanoma patients is safe. The vaccine produces strong, specific, long-lasting antitumor activity.
Go to Previous Page
Go to Next Page

Source & Additional Reading

G. Dranoff et al., Journal of Clinical Oncology, September 1, 2003.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW October 2003

Purchase Downloadable Full-text PDF of Complete Issue: $20.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login